MyMD Pharmaceuticals Inc (MYMD)

[knuts4oe]

Have struggled with the patents in the hope of understanding more of what MYMD-1 can do other than limiting inflammation, but lack the background to grasp their complex explanations of the chemistry involved. In addition to the question of whether eliminating excess inflammation will result in resolving damage of previous excess inflammation, is the question of whether or not it would be desirable to prescribe MYMD-1 as soon as it is determined that excess inflammation is the major contributor to the disease condition, as seems to be the case in the current situation with young children being hospitalized in increased numbers!